Arizona State Retirement System Purchases 9,723 Shares of Hims & Hers Health, Inc. (NYSE:HIMS)

Arizona State Retirement System increased its stake in shares of Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) by 23.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 51,327 shares of the company's stock after acquiring an additional 9,723 shares during the quarter. Arizona State Retirement System's holdings in Hims & Hers Health were worth $1,241,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Victory Capital Management Inc. increased its position in Hims & Hers Health by 1.9% during the fourth quarter. Victory Capital Management Inc. now owns 52,579 shares of the company's stock worth $1,271,000 after acquiring an additional 1,002 shares during the period. Keybank National Association OH bought a new position in Hims & Hers Health during the fourth quarter worth $237,000. Cornerstone Investment Partners LLC bought a new stake in Hims & Hers Health in the 4th quarter valued at $240,000. Charles Schwab Investment Management Inc. increased its holdings in Hims & Hers Health by 7.8% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,796,838 shares of the company's stock valued at $43,448,000 after buying an additional 129,416 shares during the period. Finally, Steward Partners Investment Advisory LLC bought a new stake in Hims & Hers Health in the 4th quarter valued at $67,000. Institutional investors own 63.52% of the company's stock.

Insider Activity

In related news, CEO Andrew Dudum sold 78,127 shares of Hims & Hers Health stock in a transaction that occurred on Monday, December 16th. The shares were sold at an average price of $29.62, for a total transaction of $2,314,121.74. Following the transaction, the chief executive officer now owns 109,956 shares of the company's stock, valued at $3,256,896.72. This trade represents a 41.54 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Michael Chi sold 7,259 shares of Hims & Hers Health stock in a transaction that occurred on Friday, January 10th. The stock was sold at an average price of $24.07, for a total transaction of $174,724.13. Following the transaction, the insider now directly owns 193,601 shares in the company, valued at $4,659,976.07. The trade was a 3.61 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 969,191 shares of company stock valued at $34,005,375. 17.71% of the stock is currently owned by insiders.

Remove Ads

Analysts Set New Price Targets

HIMS has been the topic of several analyst reports. Morgan Stanley lowered shares of Hims & Hers Health from an "overweight" rating to an "equal weight" rating and boosted their price target for the company from $42.00 to $60.00 in a report on Tuesday, February 18th. Canaccord Genuity Group boosted their target price on shares of Hims & Hers Health from $38.00 to $68.00 and gave the company a "buy" rating in a research note on Wednesday, February 19th. Piper Sandler boosted their target price on shares of Hims & Hers Health from $24.00 to $35.00 and gave the company a "neutral" rating in a research note on Tuesday, February 25th. BTIG Research started coverage on shares of Hims & Hers Health in a research note on Tuesday, January 7th. They issued a "buy" rating and a $35.00 target price on the stock. Finally, Citigroup restated a "sell" rating and issued a $27.00 target price on shares of Hims & Hers Health in a research note on Thursday, March 6th. Two analysts have rated the stock with a sell rating, seven have issued a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and an average price target of $37.23.

Hims & Hers Health Trading Up 5.0 %

NYSE HIMS traded up $1.56 on Friday, hitting $33.10. 17,052,310 shares of the company were exchanged, compared to its average volume of 13,517,903. The firm has a 50 day moving average of $38.49 and a two-hundred day moving average of $28.13. The company has a market cap of $7.35 billion, a P/E ratio of 75.24 and a beta of 1.37. Hims & Hers Health, Inc. has a 1-year low of $11.20 and a 1-year high of $72.98.

Hims & Hers Health (NYSE:HIMS - Get Free Report) last issued its earnings results on Monday, February 24th. The company reported $0.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.09 by $0.02. The company had revenue of $481.14 million for the quarter, compared to analyst estimates of $494.56 million. Hims & Hers Health had a net margin of 8.19% and a return on equity of 10.97%. Research analysts anticipate that Hims & Hers Health, Inc. will post 0.29 EPS for the current fiscal year.

About Hims & Hers Health

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.